Tumor hypoxia region

The "tumor hypoxia region" refers to areas within a solid tumor that have reduced oxygen concentrations, a common feature arising as tumors grow faster than their blood supply can support. These hypoxic zones occur due to inadequate, disorganized tumor vasculature and are characterized by oxygen tensions far below those of normal tissues, sometimes reaching <10 mmHg. Tumor hypoxia is associated with malignant progression, as it creates a selection pressure for cancer cells to adapt by altering metabolism, promoting angiogenesis (primarily through HIF-1_α mediated transcriptional changes), resisting apoptosis, increasing motility, and enhancing resistance to chemotherapy and radiotherapy. The molecular responses to hypoxia, primarily via hypoxia-inducible factors such as HIF-1_α, are major foci of therapeutic development. Drugs that indirectly target hypoxic tumor regions aim at the HIF pathway and downstream effectors, but "tumor hypoxia region" itself is neither a molecule nor a specific drug target, but rather a spatial, physiological phenomenon. Note: Because "tumor hypoxia region" is not a molecule, receptor, or defined protein, but rather a pathological feature or microenvironment of solid tumors, its use as a drug target name is incorrect, though hypoxia-associated pathways (e.g., HIFs) are considered legitimate molecular targets.

Other names

Tumor hypoxic regionHypoxic tumor microenvironmentTumor hypoxiaHypoxic regions in tumors